Bucetin: Difference between revisions

From WikiMD's Wellness Encyclopedia

CSV import
CSV import
 
Line 1: Line 1:
'''Bucetin''' is a chemical compound that was once used as an analgesic and antipyretic. The drug is a member of the aniline analgesics, which are derivatives of aniline, and was available in some countries for the relief of pain and fever. However, due to safety concerns, its use has been discontinued in many places.
{{short description|An overview of Bucetin, its uses, and properties}}


==Chemistry==
==Bucetin==
Bucetin is chemically known as 4-acetamidophenyl acetate. It is synthesized from paracetamol (acetaminophen), which is a more commonly known and used analgesic and antipyretic. The chemical structure of bucetin makes it similar to other aniline analgesics, which are characterized by the presence of an aniline moiety, a building block in organic chemistry that consists of a benzene ring attached to an amino group (NH2).
[[File:Bucetin.svg|thumb|right|Chemical structure of Bucetin]]
'''Bucetin''' is a pharmaceutical compound that was historically used as an analgesic and antipyretic. It belongs to the class of drugs known as [[aniline derivatives]], which are related to [[phenacetin]] and [[paracetamol]].
 
==Chemical Properties==
Bucetin is chemically known as N-(4-ethoxyphenyl)acetamide. It is a white crystalline powder that is soluble in organic solvents but has limited solubility in water. The chemical structure of Bucetin is similar to that of other aniline derivatives, which contributes to its pharmacological effects.


==Pharmacology==
==Pharmacology==
The mechanism of action of bucetin, like that of other aniline analgesics, involves the inhibition of the enzyme cyclooxygenase (COX). This enzyme is crucial in the biosynthesis of prostaglandins, which are lipid compounds that have various roles in the body, including the induction of inflammation, pain, and fever. By inhibiting COX, bucetin reduces the production of prostaglandins, thereby alleviating pain and reducing fever.
Bucetin acts by inhibiting the synthesis of [[prostaglandins]], which are compounds involved in the mediation of pain and fever. This mechanism is similar to that of other non-steroidal anti-inflammatory drugs (NSAIDs), although Bucetin is not classified as an NSAID.


==Clinical Use==
==Medical Uses==
Bucetin was used for the relief of mild to moderate pain and to reduce fever. Its indications were similar to those of other over-the-counter analgesics, such as paracetamol and ibuprofen. However, the use of bucetin has been phased out in many countries due to concerns over its safety profile, particularly its potential for causing liver damage with long-term use or overdose, a risk shared with other aniline analgesics.
Historically, Bucetin was used to relieve mild to moderate pain and to reduce fever. However, due to concerns about its safety profile, particularly its potential to cause [[methemoglobinemia]] and [[renal toxicity]], its use has been largely discontinued in favor of safer alternatives such as [[paracetamol]].


==Safety and Side Effects==
==Safety and Toxicity==
The safety concerns associated with bucetin primarily revolve around its potential to cause hepatotoxicity (liver damage). The risk of liver damage is a common concern with the use of aniline analgesics, especially when taken in large doses or for prolonged periods. Other possible side effects of bucetin include allergic reactions, gastrointestinal disturbances, and renal (kidney) impairment.
The use of Bucetin has been associated with several adverse effects. One of the most significant concerns is its potential to cause methemoglobinemia, a condition where hemoglobin is oxidized to methemoglobin, reducing its ability to carry oxygen. Additionally, Bucetin has been linked to renal toxicity, which can lead to kidney damage with prolonged use.


==Regulatory Status==
==Regulatory Status==
Due to the aforementioned safety concerns, the regulatory status of bucetin has changed over the years. It has been withdrawn from the market in several countries, and its use is no longer recommended. Regulatory agencies in various countries have assessed the risk-benefit profile of bucetin and have concluded that the risks associated with its use outweigh the benefits.
Due to its safety concerns, Bucetin is no longer widely used in clinical practice. It has been withdrawn from the market in many countries and is not recommended for use as an analgesic or antipyretic.


==Conclusion==
==Related pages==
While bucetin was once a commonly used analgesic and antipyretic, its use has significantly declined due to safety concerns. The medical community and regulatory agencies emphasize the importance of using safer alternatives for the management of pain and fever.
* [[Phenacetin]]
* [[Paracetamol]]
* [[Analgesic]]
* [[Antipyretic]]
* [[Methemoglobinemia]]


[[Category:Analgesics]]
[[Category:Analgesics]]
[[Category:Antipyretics]]
[[Category:Antipyretics]]
[[Category:Withdrawn drugs]]
[[Category:Withdrawn drugs]]
{{Pharmacology-stub}}
{{No image}}

Latest revision as of 03:49, 13 February 2025

An overview of Bucetin, its uses, and properties


Bucetin[edit]

Chemical structure of Bucetin

Bucetin is a pharmaceutical compound that was historically used as an analgesic and antipyretic. It belongs to the class of drugs known as aniline derivatives, which are related to phenacetin and paracetamol.

Chemical Properties[edit]

Bucetin is chemically known as N-(4-ethoxyphenyl)acetamide. It is a white crystalline powder that is soluble in organic solvents but has limited solubility in water. The chemical structure of Bucetin is similar to that of other aniline derivatives, which contributes to its pharmacological effects.

Pharmacology[edit]

Bucetin acts by inhibiting the synthesis of prostaglandins, which are compounds involved in the mediation of pain and fever. This mechanism is similar to that of other non-steroidal anti-inflammatory drugs (NSAIDs), although Bucetin is not classified as an NSAID.

Medical Uses[edit]

Historically, Bucetin was used to relieve mild to moderate pain and to reduce fever. However, due to concerns about its safety profile, particularly its potential to cause methemoglobinemia and renal toxicity, its use has been largely discontinued in favor of safer alternatives such as paracetamol.

Safety and Toxicity[edit]

The use of Bucetin has been associated with several adverse effects. One of the most significant concerns is its potential to cause methemoglobinemia, a condition where hemoglobin is oxidized to methemoglobin, reducing its ability to carry oxygen. Additionally, Bucetin has been linked to renal toxicity, which can lead to kidney damage with prolonged use.

Regulatory Status[edit]

Due to its safety concerns, Bucetin is no longer widely used in clinical practice. It has been withdrawn from the market in many countries and is not recommended for use as an analgesic or antipyretic.

Related pages[edit]